Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor

PURPOSE: Thoracic SMARCA4-deficient undifferentiated tumor (SD-UT) is a highly aggressive disease that is nosologically related to but distinct from SMARCA4-deficient non-small cell lung cancer (SD-NSCLC). No standard treatment guidelines were established for SD-UT. This research explored the effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ying, Yu, Bo, Sun, Haifeng, Zhang, Hongyu, Hu, Zhihuang, Zhang, Yao, Wu, Zhenhua, Sun, Si, Zhao, Xinmin, Yu, Hui, Wu, Xianghua, Li, Yuan, Wang, Jialei, Wang, Huijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374696/
https://www.ncbi.nlm.nih.gov/pubmed/37115272
http://dx.doi.org/10.1007/s00432-023-04806-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374696/
https://www.ncbi.nlm.nih.gov/pubmed/37115272
http://dx.doi.org/10.1007/s00432-023-04806-y

Ejemplares similares